What they were paid
CONMED Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $105,362 | $36,994 | $148,000 | $0 | $290,356 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CONMED Corp DEF 14A filed April 7, 2026, accession 0000816956-26-000047, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025CONMED pays directors a $70,000 cash retainer and $185,000 in Stock Options (80%) and RSUs (20%).
Committees
FY2025 · as the proxy prints themAudit (Chair) · Compensation
The rest of the CONMED board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Brian P. Concannon | Independent Director | $279,994 |
| Charles M. Farkas | Independent Director | $278,746 |
| David Bronson | Independent Director | $282,134 |
| Kim Kelderman | Independent Director | $161,721 |
| LaVerne H. Council | Chair of the Board | $308,004 |
| Mark Kaye | Independent Director | $310,733 |
| Patrick J. Beyer | Director | $0 |
The full CONMED compensation record
free company briefThis page is one director within CONMED's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat